Immuron Limited
USD1.06
-0.02 (-1.85%)
CEO
Steven George Lydeamore
IPO Date
2017-06-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
AU
Open
$1.05
Prev. Close
$1.08
Day Low
$0.99
Day High
$1.10
52W Low
$0.68
52W High
$2.39
Market Cap
$0.01B
Volume
0.05M
| -2.7 |
| 30 Jun 2023 | FY | 72.5% | -209.8% | -19.3% | -17.2% | 0.01 | 9.20 | -4.5 |
| 30 Jun 2022 | FY | 68.4% | -373.0% | -12.3% | -11.5% | 0.01 | 15.75 | -6.3 |
| 30 Jun 2021 | FY | 65.0% | -5751.6% | -32.4% | -31.0% | 0.00 | 22.96 | -4.2 |
| 30 Jun 2020 | FY | 72.6% | -116.2% | -51.9% | -47.2% | 0.01 | 8.54 | -15.7 |
| 30 Jun 2019 | FY | 71.5% | -195.0% | -63.3% | -54.4% | 0.00 | 5.59 | -3.9 |
| 30 Jun 2018 | FY | 68.4% | -163.4% | -35.7% | -32.6% | 0.00 | 8.78 | -15.1 |
| 30 Jun 2017 | FY | 66.0% | -487.3% | -103.5% | -82.1% | 0.06 | 4.83 | -4.2 |
| 30 Jun 2016 | FY | 69.5% | -706.1% | -143.1% | -80.1% | 0.38 | 2.27 | -2.7 |
| -1.3 |
| 31 Dec 2024 | Q2 | 66.5% | -62.3% | -24.1% | -20.5% | 0.01 | 6.80 | -1.8 |
| 30 Jun 2024 | Q4 | 69.0% | -190.9% | -38.3% | -31.3% | 0.01 | 5.46 | -1.0 |
| 31 Dec 2023 | Q2 | 67.1% | -88.0% | -11.8% | -10.4% | 0.01 | 8.52 | -2.1 |
| 30 Jun 2023 | Q4 | 72.2% | -148.1% | -9.2% | -8.2% | 0.01 | 9.20 | -2.4 |
| 31 Dec 2022 | Q2 | 73.3% | -339.0% | -9.3% | -8.6% | 0.01 | 12.11 | -2.5 |
| 30 Jun 2022 | Q4 | 67.8% | -195.2% | -4.5% | -4.2% | 0.01 | 15.75 | -4.3 |
| 31 Dec 2021 | Q2 | 69.9% | -784.3% | -7.5% | -7.1% | 0.01 | 23.75 | -3.1 |
| 30 Jun 2021 | Q4 | 69.2% | -2108.7% | -10.2% | -9.8% | 0.00 | 22.96 | -3.4 |